Ecuador central bank sees 3.1% growth in 2021 after contraction

Reuters
·1 min read

QUITO, Dec 1 (Reuters) - Ecuador's central bank said on Tuesday it expected the Andean country's economy to expand by 3.1% in 2021, following an 8.9% contraction in 2020 due to a plunge in crude prices and the effects of the coronavirus pandemic.

In a report, the bank said it expected household spending and a rebound in remittances from abroad to lead the expansion, together with a likely rebound in oil exports, the main external source of revenue in Ecuador's dollarized economy. Imports were also expected to grow some 3.2% next year.

"This is due to an improvement in the domestic economy's dynamics," the central bank said. The International Monetary Fund (IMF) said last week that growth would gradually recover in the medium term, but that Ecuador should expect "significant uncertainty" around the future trajectory of the pandemic and global crude prices.

Ecuador's cash-strapped government is currently awaiting the IMF board's approval for the disbursement of a $2 billion tranche of a $6.5 billion financing arrangement signed in September. (Reporting by Alexandra Valencia in Quito Writing by Luc Cohen)

  • Up next
  • Up next
  • Up next
  • Up next

Latest Stories

  • New ‘cold war’ grows ever warmer as the prospect of a nuclear arms race hots up

    Nuclear proliferation is gathering pace as global tensions rise.

  • Metso Corp's Dividend Analysis

    Metso Corp(OUKPY) recently announced a dividend of $0.1 per share, payable on 2024-05-22, with the ex-dividend date set for 2024-04-26. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Metso Corp's dividend performance and assess its sustainability.

  • Supreme Court to hear high-stakes arguments on Trump’s presidential immunity in criminal case: Live

    Decision on immunity question could impact what charges Republican presidential contender faces and whether they go to trial before November’s election

  • Elizabeth Hurley says having son Damian direct film sex scene was not ‘a big deal’

    Damian Hurley is the director of his mother’s latest picture, ‘Strictly Confidential’

  • Labour more popular than Tories with GB News viewers

    Labour is more popular with viewers of GB News than the Tories, a new poll has revealed.

  • Alfa Laval AB's Dividend Analysis

    Alfa Laval AB (ALFVY) recently announced a dividend of $0.71 per share, payable on 2024-05-20, with the ex-dividend date set for 2024-04-26. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Alfa Laval AB's dividend performance and assess its sustainability.

  • Supercar maker McLaren hit by £375m impairment charge

    McLaren Group, the British supercar maker and Formula One team-backer, has given lenders signs of an improvement in its financial performance even after a £375m impairment charge propelled it to a record loss last year. Sky News has learnt that McLaren has told bondholders that it made losses of £873m in the 12 months ending December 31. The Woking-based company's financial travails reflected an ongoing financial restructuring that was completed earlier this year.

  • Celanese Corp's Dividend Analysis

    Celanese Corp(NYSE:CE) recently announced a dividend of $0.7 per share, payable on 2024-05-13, with the ex-dividend date set for 2024-04-26. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Celanese Corps dividend performance and assess its sustainability.

  • Q1 2024 Quantumscape Corp Earnings Call

    Q1 2024 Quantumscape Corp Earnings Call

  • What kind of food can you expect at Buc-ee’s in Florida? We hit the road to get a taste

    THere’s what to try and what to skip on your trip.

  • Senate Passes $95 Billion Foreign Aid Package

    On April 23, the U.S. Senate voted 79-18 to approve foreign aid for Ukraine, Israel and Taiwan, 'The Guardian' reports. "Today the Senate sends a unified message to the entire world: America will always defend democracy in its hour of need.", Senate Majority Leader Chuck Schumer, via statement.

  • How to make the perfect egg sandwich

    The beloved egg sandwich has long been a staple of desk lunches, afternoon tea and picnic baskets and it’s one of the easiest (and cheapest) sandwiches to make at home.

  • Comcast tops revenue estimates on streaming growth, strong park attendance

    Peacock added 3 million subscribers in the first quarter, taking its total to 34 million and outpacing estimates of 2.32 million by Visible Alpha, thanks to higher investments that Comcast hopes will help it compete better with Netflix and Disney+. Peacock became the first streaming service to exclusively air an NFL playoff game in January, which was one of its biggest growth drivers in the quarter.

  • UCB SA's Dividend Analysis

    UCB SA (UCBJY) recently announced a dividend of $0.73 per share, payable on 2024-05-15, with the ex-dividend date set for 2024-04-26. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into UCB SA's dividend performance and assess its sustainability.

  • Sampo Oyj's Dividend Analysis

    Sampo Oyj (SAXPY) recently announced a dividend of $0.97 per share, payable on 2024-05-22, with the ex-dividend date set for 2024-04-26. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Sampo Oyj's dividend performance and assess its sustainability.

  • UPDATE 1-Merck raises 2024 profit forecast on strong sales of cancer drug Keytruda

    Merck & Co on Thursday raised its annual profit and revenue forecast on the back of strong sales for its blockbuster cancer drug Keytruda. The New Jersey-based drugmaker said it expected earnings of $8.53 and $8.65 per share, up from its previous forecast of $8.44 to $8.59, and sales of $63.1-$64.3 billion for the year. Merck's new forecast includes a $0.26 per share charge for its $680 million acquisition of cancer drug developer Harpoon Therapeutics, which closed in the first quarter of 2024, the company said.

  • Shoplifting offences soar to highest level in 20 years, new figures show

    More than 100,000 more shoplifting offences were recorded in 2023 than the previous year, figures reveal

  • Premier League news LIVE: Van Dijk questions Liverpool team-mates’ desire after blowing title challenge

    The Reds are now three points behind Arsenal while Manchester City have two games in hand on the leaders

  • Ryanair cancels 300 flights across Europe as French air traffic controllers go on strike

    Budget airline’s chief calls on EU to protect overflights and allow other European controllers to manage flights in French airspace

  • Nasdaq's revenue beats on strong demand for fintech products

    Revenue from its financial technology unit surged 71% to $392 million in the first quarter, while revenue from its index business jumped 53% to $168 million. Nasdaq, like its peers, has been on an acquisition spree to diversify its portfolio of technology and intellectual property after regulations in 2005 opened the equities trading market up to competition from brokers. Net revenue in the first quarter jumped 22% to $1.12 billion.